The scientist’s investigation covers issues in Epilepsy, Pregnancy, Pediatrics, Genetics and Anesthesia. His biological study spans a wide range of topics, including Cognition and Electroencephalography. His research in Pregnancy intersects with topics in Cancer, Psychiatry, Anxiety and Cohort study.
His studies deal with areas such as Neurocognitive, Ataxia and Genetic heterogeneity as well as Pediatrics. His Genetics research is multidisciplinary, incorporating elements of Molecular biology and Immunology. His biological study spans a wide range of topics, including Clinical trial, Adverse effect, Lennox–Gastaut syndrome, Neurological disorder and Symptomatic generalised epilepsy.
Lieven Lagae spends much of his time researching Epilepsy, Pediatrics, Anesthesia, Electroencephalography and Neuroscience. His Epilepsy study contributes to a more complete understanding of Psychiatry. His Pediatrics study which covers Pregnancy that intersects with Cancer.
The Anesthesia study combines topics in areas such as Adverse effect and Fenfluramine. His research in Electroencephalography intersects with topics in Audiology, Artificial intelligence and Pattern recognition. He specializes in Neuroscience, namely Visual cortex.
His primary areas of investigation include Epilepsy, Pediatrics, Dravet syndrome, Fenfluramine and Tuberous sclerosis. The various areas that Lieven Lagae examines in his Epilepsy study include Adverse effect, Pharmacology, Intensive care medicine and Electroencephalography. His Electroencephalography study integrates concerns from other disciplines, such as Audiology, Artificial intelligence and Pattern recognition.
Lieven Lagae has researched Pediatrics in several fields, including Pregnancy, Cancer, Disease and Intellectual disability. Lieven Lagae interconnects Epilepsy syndromes, Clinical trial, Serotonergic and Cohort in the investigation of issues within Dravet syndrome. His Fenfluramine study combines topics in areas such as Anesthesia and Open label, Extension study.
His primary areas of investigation include Epilepsy, Dravet syndrome, Fenfluramine, Pediatrics and Anesthesia. His research integrates issues of Position paper, Pharmacology and Electroencephalography in his study of Epilepsy. His studies in Dravet syndrome integrate themes in fields like Cannabidiol, Alternative splicing, Exon, Intensive care medicine and Cohort.
Lieven Lagae has included themes like Retrospective cohort study, Quality of life, Tuberous sclerosis and Intellectual disability in his Pediatrics study. His Anesthesia research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Adverse effect, Pulmonary hypertension, Effective dose and Epilepsy syndromes. His Eyelid myoclonia research integrates issues from Epileptic spasms, Cognition and Audiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology
Robert S. Fisher;J. Helen Cross;Jacqueline A. French;Norimichi Higurashi.
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.
Lieve Claes;Jurgen Del-Favero;Berten Ceulemans;Lieven Lagae.
American Journal of Human Genetics (2001)
Instruction manual for the ILAE 2017 operational classification of seizure types
Robert S. Fisher;J. Helen Cross;Carol D'Souza;Jacqueline A. French.
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response.
Gillian I Rice;Jacquelyn Bond;Aruna Asipu;Rebecca L Brunette.
Nature Genetics (2009)
Antenatal Maternal Anxiety is Related to HPA-Axis Dysregulation and Self-Reported Depressive Symptoms in Adolescence: A Prospective Study on the Fetal Origins of Depressed Mood
Bea R H Van den Bergh;Ben Van Calster;Tim Smits;Sabine Van Huffel.
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling
Gillian I Rice;Yoandris del Toro Duany;Yoandris del Toro Duany;Emma M Jenkinson;Gabriella M A Forte.
Nature Genetics (2014)
KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.
Sarah Weckhuysen;Simone Mandelstam;Arvid Suls;Dominique Audenaert;Dominique Audenaert.
Annals of Neurology (2012)
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.
Yanick J. Crow;Diana S. Chase;Johanna Lowenstein Schmidt;Marcin Szynkiewicz.
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
Gillian Rice;Teresa Patrick;Rekha Parmar;Claire F Taylor.
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Markus Wolff;Katrine M Johannesen;Ulrike B S Hedrich;Silvia Masnada.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: